Cipro and Daliresp drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cipro (ciprofloxacin hydrochloride) and Daliresp (roflumilast). Common drug interactions include haemorrhage among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Cipro and Daliresp. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Cipro?

Cipro has active ingredients of ciprofloxacin hydrochloride. It is often used in urinary tract infection. eHealthMe is studying from 35,126 Cipro users. Check the latest studies of Cipro.

What is Daliresp?

Daliresp has active ingredients of roflumilast. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 4,722 Daliresp users. Check the latest studies of Daliresp.

On Jul, 11, 2026

21 people who take Cipro and Daliresp together, and have interactions are studied.

What are the common drug interactions of Cipro and Daliresp, by gender? *:

female:

Haemorrhage (bleeding)
Infusion site erythema (reddening of the skin at infusion site)
Infusion site pain
Infusion site rash
Infusion site urticaria (rash of round, red welts on the skin at infusion site)
Kidney infection
Pneumonia
Seasonal allergy (allergic condition due to certain season)
Vascular injury
Diarrhoea

male:

Death
Hospitalisation
Nasopharyngitis (inflammation of the nasopharynx)

What are the common drug interactions of Cipro and Daliresp, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Cellulitis (infection under the skin)
Oxygen saturation decreased

50-59:

Chronic kidney disease
Drug dependence
Dyspnoea (difficult or laboured respiration)
Panic attack
Suicidal ideation
Upper respiratory tract infection

60+:

Sinusitis (inflammation of sinus)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Infusion site pain
Infusion site rash
Infusion site urticaria (rash of round, red welts on the skin at infusion site)
Kidney infection
Multiple allergies (allergy to multiple agents)
Pneumonia
Rib fracture
Seasonal allergy (allergic condition due to certain season)

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 4 people, 19.05%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 14.29%
Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 2 people, 9.52%
Pain: 2 people, 9.52%
Nausea And Vomiting: 2 people, 9.52%
Nausea (feeling of having an urge to vomit): 2 people, 9.52%
Hypersensitivity: 2 people, 9.52%
High Blood Pressure: 2 people, 9.52%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 9.52%
Dyspnea (difficult or laboured breathing): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Cipro and Daliresp?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously